Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05702580
Other study ID # 0107486
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 15, 2022
Est. completion date August 2023

Study information

Verified date January 2023
Source Alexandria University
Contact Ahmed S Sadaka, PhD
Phone +201005433152
Email ahmad.sadaka@alexmed.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to compare the microbiologic diagnostic yield of pre-aspiration agitated pleural fluid versus that of conventionally aspirated fluid in pleural infection patients. The main question it aims to answer is, whether fluid agitation helps to increase the microbiological yield.


Description:

In pleural infection, It is suggested that the bacteria being diagnostically targeted, might more likely be residing on the pleural surface with a better blood supply and nutrition rather than being planktonic in the acidic, glucose deficient pleural fluid. The investigators thus hypothesize that an agitation of the pleural fluid prior to sample aspiration would aid in achieving a better cellular representation of the pleural space. This could have the effect of washing bacterial cells off the pleural surface as well as moving sedimented cells in the aspirated sample. This study aims to investigate whether an increase in the microbiological yield for infected pleural fluid could be achieved by a pre-aspiration agitation of the pleural fluid which would have a positive effect on management and eventual patient outcomes. Adult participants with pleural infection will undergo thoracentesis via both the standard and agitated fluid techniques guided by thoracic ultrasound. Microbiological yields will be compared.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date August 2023
Est. primary completion date August 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age >18 years old 2. Pleural infection based on clinical presentation, imaging or laboratory investigations and pleural fluid examination showing glucose < 40 mg/dL or pH <7.2 with lower respiratory infection or pus on aspiration 3. At least a moderate amount of pleural fluid collection (2 or more intercostal spaces on thoracic ultrasound) Exclusion Criteria: 1. Minimal - mild pleural fluid deemed unsuitable for aspiration and agitation 2. Hemodynamic instability 3. Uncorrected coagulopathy 4. Transudative or exudative lymphocytic pleural effusion on biochemical analysis

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Agitated Pleural Fluid Thoracentesis
Using a 16-18 gauge cannula, a standard thoracentesis will be performed then a sample of pleural fluid will be aspirated and rapidly flushed into the pleural space and redrawn again for a few cycles before a sample is finally drawn into the collection syringe

Locations

Country Name City State
Egypt Chest Diseases Department, Alexandria University Faculty of Medicine Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Alexandria University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic yield of the microbiologic analysis Percentage of samples with a positive microbiologic result among both aspiration techniques results within 1 week of sampling
Secondary LDH level difference between both aspiration methods Difference in LDH levels in the aspirated fluid via both techniques results within 1 day of sampling
Secondary Glucose level difference between both aspiration methods Difference in glucose levels in the aspirated fluid via both techniques results within 1 day of sampling
Secondary Protein level difference between both aspiration methods Difference in protein levels in the aspirated fluid via both techniques results within 1 day of sampling
Secondary Neutrophilic count difference between both aspiration methods Difference in neutrophilic count in the aspirated fluid via both techniques results within 1 day of sampling
Secondary Lymphocytic count difference between both aspiration methods Difference in lymphocytic count in the aspirated fluid via both techniques results within 1 day of sampling
See also
  Status Clinical Trial Phase
Completed NCT04615286 - Short Versus Long Antibiotic Course for Pleural Infection Management (SLIM Trial) N/A
Recruiting NCT05910112 - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Recruiting NCT06141174 - Predictors of Outcome in Patients With Pleural Infection at Sohag University Hospital
Completed NCT03468933 - Fibrinolysis Compared to Thoracoscopy for Pleural Infection Phase 4
Not yet recruiting NCT04301869 - Oral Versus Intravenous Antibiotics for the Treatment of Pleural Space Infection: a Randomized Controlled Pilot Trial N/A
Completed NCT02608814 - Advanced Ultrasound in Pleural Infection N/A
Completed NCT04761133 - Antiseptic Irrigation for Pleural Infection Phase 1
Not yet recruiting NCT05766124 - Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE) Phase 2/Phase 3
Not yet recruiting NCT06427538 - Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas N/A
Completed NCT02973139 - Fibrinolysis Compared to Thoracoscopy for Pleural Infection N/A
Recruiting NCT05903417 - Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic N/A
Not yet recruiting NCT06434324 - Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion N/A
Completed NCT04569110 - The Microbiology of Pleural Infection
Completed NCT04350502 - Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections N/A